Probiotics for human health -new innovations and emerging trends

Gut Pathogens

Volumn 4, Issue 1, 2012, Pages

  Grover, Sunita ^a   Rashmi, Hogarehalli Mallapa ^a   Srivastava, Anil Kumar ^a   Batish, Virender Kumar ^a  

^a NATIONAL DAIRY RESEARCH INSTITUTE   (India)

Author keywords

Clinical evidence; Gut microbiota; Health benefits; Probiotics

Indexed keywords

EID: 84872310434     PISSN: None     EISSN: 17574749     Source Type: Journal    
DOI: 10.1186/1757-4749-4-15     Document Type: Conference Paper

References (35)

1. Whole-genome shotgun sequencing of an Indian-origin Lactobacillus helveticus strain, MTCC 5463, with probiotic potential. Prajapati JB, Khedkar CD, Chitra J, Suja S, Mishra V, Sreeja V, Patel RK, Ahir VB, Bhatt VD, Sajnani MR, Sajnani MR, Jakhesara SJ, Koringa PG, Joshi CG, J Bacteriol 2011 193 16 4282 4283
2. Expression of the atpD gene in probiotic Lactobacillus plantarum strains under in vitro acidic conditions using RT-qPCR. Duary RK, Batish VK, Grover S, Res Microbiol 2010 161 5 399 405
3. Relative gene expression of bile salt hydrolase and surface proteins in two putative indigenous Lactobacillus plantarum strains under in vitro gut conditions. Duary RK, Batish V, Grover S, Mol Biol Rep 2012 39 3 2541 2552
4. Anti-inflammatory and immunomodulatory efficacy of indigenous probiotic Lactobacillus plantarum Lp91 in colitis mouse model. Duary RK, Bhausaheb MA, Batish VK, Grover S, Mol Biol Rep 2012 39 4 4765 4775
5. Assessing the adhesion of putative indigenous probiotic lactobacilli to human colonic epithelial cells. Duary RK, Rajput YS, Batish VK, Grover S, Indian J Med Res 2011 134 664 671
6. Lactobacillus plantarum (VR1) isolated from an Ayurvedic medicine (Kutajarista) ameliorates in vitro cellular damage caused by Aeromonas veronii. Kumar H, Rangrez A, Dayananda K, Atre A, Patole M, Shouche Y, BMC Microbiol 2011 11 1 152
7. Executive summary: scientific and regulatory challenges of development of probiotics as foods and drugs. Hoffman FA, Heimbach JT, Sanders ME, Hibberd PL, Clin Infect Dis 2008 46 2 53 S57
8. Probiotics and gastrointestinal disease: successes, problems and future prospects. Culligan E, Hill C, Sleator R, Gut Pathog 2009 1 1 19
9. Microbial contact during pregnancy, intestinal colonization and human disease. Rautava S, Luoto R, Salminen S, Isolauri E, Nat Rev Gastroenterol Hepatol 2012 9 10 565 576
10. The human milk microbiome changes over lactation and is shaped by maternal weight and mode of delivery. Cabrera-Rubio R, Collado MC, Laitinen K, Salminen S, Isolauri E, Mira A, Am J Clin Nutr 2012 96 3 544 551
11. Health claims in Europe: probiotics and prebiotics as case examples. van Loveren H, Sanz Y, Salminen S, Annu Rev Food Sci Technol 2012 3 247 261
12. Diversity, stability and resilience of the human gut microbiota. Lozupone CA, Stombaugh JI, Gordon JI, Jansson JK, Knight R, Nat 2012 489 7415 220 230
13. Probiotics, prebiotics and synbiotics: Gut and beyond. Vyas U, Ranganathan N, Gastroenterol Res Pract 2012 2012 1 16
14. Induction of colonic regulatory T cells by indigenous Clostridium Species. Atarashi K, Tanoue T, Shima T, Imaoka A, Kuwahara T, Momose Y, Cheng G, Yamasaki S, Saito T, Ohba Y, Taniguchi T, Takeda K, Hori S, Ivanov II, Umesaki Y, Itoh K, Honda K, Sci 2011 331 6015 337 341
15. Mechanisms of disease: the hygiene hypothesis revisited. Guarner F, Bourdet-Sicard R, Brandtzaeg P, Gill HS, McGuirk P, van Eden W, Versalovic J, Weinstock JV, Rook GA, Nat Clin Pract Gastroenterol Hepatol 2006 3 275 284 (Pubitemid 43675024)
16. Linking long-term dietary patterns with gut microbial enterotypes. Wu GD, Chen J, Hoffmann C, Bittinger K, Chen YY, Keilbaugh SA, Bewtra M, Knights D, Walters WA, Knight R, Sinha R, Gilroy E, Gupta K, Baldassano R, Nessel L, Li H, Bushman FD, Lewis JD, Sci 2011 334 6052 105 108
17. The impact of a consortium of fermented milk strains on the gut microbiome of gnotobiotic mice and monozygotic twins. McNulty NP, Yatsunenko T, Hsiao A, Faith JJ, Muegge BD, Goodman AL, Henrissat B, Oozeer R, Cools-Portier S, Gobert G, Chervaux C, Knights D, Lozupone CA, Knight R, Duncan AE, Bain JR, Muehlbauer MJ, Newgard C, Heath AC, Gordon JI, Sci Transl Med 2011 3 106 106
18. Gut microbiota in human adults with type 2 diabetes differs from non-diabetic adults. Larsen N, Vogensen FK, van den Berg FWJ, Nielsen DS, Andreasen AS, Pedersen BK, Al-Soud WA, Sørensen SJ, Hansen LH, Jakobsen M, PLoS One 2010 5 2 9085
19. Metagenome of the gut of a malnourished child. Gupta S, Mohammed M, Ghosh T, Kanungo S, Nair G, Mande S, Gut Pathog 2011 3 1 7
20. Gut microbiota and probiotics in maternal and infant health. Sanz Y, Am J Clin Nutr 2011 94 6 2000S 2005S
21. A meta-analysis of probiotic efficacy for gastrointestinal diseases. Ritchie ML, Romanuk TN, PLoS One 2012 7 4 34938
22. Role of probiotic in preventing acute diarrhoea in children: a community-based, randomized, double-blind placebo-controlled field trial in an urban slum. Sur D, Manna B, Niyogi SK, Ramamurthy T, Palit A, Nomoto K, Takahashi T, Shima T, Tsuji H, Kurakawa T, Takeda Y, Nair GB, Bhattacharya SK, Epidemiol Infect 2011 139 06 919 926
23. Increased risk of necrotizing enterocolitis in premature infants with patent ductus arteriosus treated with indomethacin. Grosfeld JL, Chaedt M, Molinari F, Ann Surg 1996 224 3 350 357 (Pubitemid 26307477)
24. Oral probiotics reduce the incidence and severity of necrotizing enterocolitis in very low birth weight infants. Lin HC, Su BH, Chen AC, Lin TW, Tsai CH, YehTF OW, Paediatr 2005 115 1 1 4
25. Updated meta-analysis of probiotics for preventing necrotizing enterocolitis in preterm neonates. Deshpande G, Rao S, Patole S, Bulsara M, Paediatr 2010 125 5 921 930
26. Dominant and diet-responsive groups of bacteria within the human colonic microbiota. Walker AW, Ince J, Duncan SH, Webster LM, Holtrop G, Ze X, ISME J 2011 5 220 230
27. Bacteriocin production as a mechanism for the antiinfective activity of Lactobacillus salivarius UCC118. Corr SC, Li Y, Riedel CU, O'Toole PW, Hill C, Gahan CGM, Proc Natl Acad Sci 2007 104 18 7617 7621 (Pubitemid 47185955)
28. Thuricin CD, a posttranslationally modified bacteriocin with a narrow spectrum of activity against Clostridium difficile. Rea MC, Sit CS, Clayton E, O'Connor PM, Whittal RM, Zheng J, Vederas JC, Ross RP, Hill C, Proc Natl Acad Sci 2010 107 20 9352 9357
29. Metabolic properties of lactobacilli in women experiencing recurring episodes of bacterial vaginosis with vaginal pH ≥ 5. Garg KB, Ganguli I, Kriplani A, Lohiya NK, Thulkar J, Talwar GP, Eur J Clin Microbiol Infect Dis 2010 29 1 123 125
30. Efficacy of probiotics in prevention of acute diarrhoea: a meta-analysis of masked, randomised, placebo-controlled trials. Sazawal S, Hiremath G, Dhingra U, Malik P, Deb S, Black RE, Lancet Infect Dis 2006 6 6 374 382 (Pubitemid 43737276)
31. The efficacy of probiotics in the treatment of irritable bowel syndrome: a systematic review. Moayyedi P, Ford AC, Talley NJ, Cremonini F, Foxx-Orenstein AE, Brandt LJ, Quigley EMM, Gut 2010 59 3 325 332
32. Treatment and prevention of pouchitis after ileal pouch-anal anastomosis for chronic ulcerative colitis. Holubar SD, Cima RR, Sandborn WJ, Pardi DS, Cochrane Database Syst Rev 2010 6 D001176
33. Placebos without deception: A randomized controlled trial in irritable bowel syndrome. Kaptchuk TJ, Friedlander E, Kelley JM, Sanchez MN, Kokkotou E, Singer JP, Kowalczykowski M, Miller FG, Kirsch I, Lembo AJ, PLoS One 2010 5 12 15591
34. Meta-analysis: factors affecting placebo response rate in the irritable bowel syndrome. Ford AC, Moayyedi P, Aliment Pharmacol Ther 2010 32 2 144 158
35. Dose-response effect of Bifidobacterium lactis HN019 on whole gut transit time and functional gastrointestinal symptoms in adults. Waller PA, Gopal PK, Leyer GJ, Ouwehand AC, Reifer C, Stewart ME, Miller LE, Scand J Gastroenterol 2011 46 9 1057 1064